Volgen
Ana Abecasis
Ana Abecasis
Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, NOVA Univ Lisboa
Geverifieerd e-mailadres voor ihmt.unl.pt
Titel
Geciteerd door
Geciteerd door
Jaar
Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools
AC Pineda-Peña, NR Faria, S Imbrechts, P Libin, AB Abecasis, ...
Infection, genetics and evolution 19, 337-348, 2013
4142013
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
AB Abecasis, AMJ Wensing, D Paraskevis, J Vercauteren, K Theys, ...
Retrovirology 10, 1-13, 2013
1872013
A genomic signature and the identification of new sporulation genes
AB Abecasis, M Serrano, R Alves, L Quintais, JB Pereira-Leal, ...
Journal of bacteriology 195 (9), 2101-2115, 2013
1472013
Quantifying differences in the tempo of human immunodeficiency virus type 1 subtype evolution
AB Abecasis, AM Vandamme, P Lemey
Journal of virology 83 (24), 12917-12924, 2009
1322009
Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form
AB Abecasis, P Lemey, N Vidal, T de Oliveira, M Peeters, R Camacho, ...
Journal of virology 81 (16), 8543-8551, 2007
1312007
Phylogeography of dengue virus serotype 4, Brazil, 2010–2011
MRT Nunes, NR Faria, HB Vasconcelos, DB de Almeida Medeiros, ...
Emerging infectious diseases 18 (11), 1858, 2012
1122012
Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G
AB Abecasis, K Deforche, J Snoeck, LT Bacheler, P McKenna, ...
Aids 19 (16), 1799-1806, 2005
1052005
A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes
V Fonseca, PJK Libin, K Theys, NR Faria, MRT Nunes, MI Restovic, ...
PLoS neglected tropical diseases 13 (5), e0007231, 2019
872019
Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG
AB Abecasis, K Deforche, LT Bacheler, P McKenna, AP Carvalho, ...
Antiviral therapy 11 (5), 581-589, 2006
832006
Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable
C Mavian, SK Pond, S Marini, BR Magalis, AM Vandamme, S Dellicour, ...
Proceedings of the National Academy of Sciences 117 (23), 12522-12523, 2020
822020
HIV and tuberculosis co-infection among migrants in Europe: A systematic review on the prevalence, incidence and mortality
AM Tavares, I Fronteira, I Couto, D Machado, M Viveiros, AB Abecasis, ...
PloS one 12 (9), e0185526, 2017
812017
Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon
NR Faria, MA Suchard, A Abecasis, JD Sousa, N Ndembi, I Bonfim, ...
Infection, Genetics and Evolution 12 (2), 453-460, 2012
702012
VIRULIGN: fast codon-correct alignment and annotation of viral genomes
PJK Libin, K Deforche, AB Abecasis, K Theys
Bioinformatics 35 (10), 1763-1765, 2019
662019
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe
D Frentz, DAMC Van de Vijver, AB Abecasis, J Albert, O Hamouda, ...
BMC Infectious Diseases 14, 1-12, 2014
612014
The impact of HIV-1 within-host evolution on transmission dynamics
K Theys, P Libin, AC Pineda-Pena, A Nowe, AM Vandamme, AB Abecasis
Current opinion in virology 28, 92-101, 2018
572018
Patterns of transmitted HIV drug resistance in Europe vary by risk group
D Frentz, D van de Vijver, A Abecasis, J Albert, O Hamouda, L Jørgensen, ...
PloS one 9 (4), e94495, 2014
542014
Limited cross-border infections in patients newly diagnosed with HIV in Europe
D Frentz, AMJ Wensing, J Albert, D Paraskevis, AB Abecasis, O Hamouda, ...
Retrovirology 10, 1-10, 2013
532013
Phylogenetic analysis as a forensic tool in HIV transmission investigations
AB Abecasis, M Pingarilho, AM Vandamme
Aids 32 (5), 543-554, 2018
502018
HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir
K Theys, J Vercauteren, J Snoeck, M Zazzi, RJ Camacho, C Torti, ...
Antimicrobial agents and chemotherapy 57 (2), 1053-1056, 2013
502013
Science in court: the myth of HIV fingerprinting
AB Abecasis, AM Geretti, J Albert, L Power, M Weait, AM Vandamme
The Lancet Infectious Diseases 11 (2), 78-79, 2011
462011
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20